[Federal Register Volume 78, Number 140 (Monday, July 22, 2013)]
[Pages 43888-43889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-17531]



Food and Drug Administration

[Docket No. FDA-2013-D-0838]

Compliance Policy Guide Sec. 253.100--Use of Units of Plasma and 
Fresh Frozen Plasma Which Have Been Thawed; Withdrawal of Compliance 
Policy Guide

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.


SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of the compliance policy guide (CPG) entitled ``Sec. 
253.100--Use of Units of Plasma and Fresh Frozen Plasma Which Have Been 
Thawed,'' issued October 1, 1980, and revised in March 1995.

DATES: The withdrawal is effective July 22, 2013.

FOR FURTHER INFORMATION CONTACT: Robert L. Hummel, Medical Products and 
Tobacco Policy Staff, Office of Policy and Risk Management, Office of 
Regulatory Affairs, Food and Drug Administration, 12420 Parklawn Dr., 
Rockville, MD 20857, 301-796-4510.

SUPPLEMENTARY INFORMATION: FDA issued the CPG entitled ``Sec. 253.100--
Use of Units of Plasma and Fresh Frozen Plasma Which Have Been Thawed'' 
on October 1, 1980, and revised it in March 1995. FDA originally issued 
CPG Sec. 253.100 to provide FDA's current thinking regarding the time 
limits for when thawed frozen plasma should be used for transfusion. At 
the time of issuance of the CPG, 21 CFR 606.122(m)(3) provided that the 
instruction circular shall include, when applicable, instructions to 
begin administration of the product within 6 hours after thawing. The 
CPG noted a planned regulatory change that would allow greater 
flexibility in the time of administration requirements for frozen 
plasma products.
    In a final rule published in the Federal Register on January 3, 
2012 (77 FR 7), with an effective date of July 2, 2012, FDA modified 
the time limits contained in the instruction circular for when 
administration of thawed frozen plasma products begins, as required by 
21 CFR 606.122(m)(3), to ``within a specified time after thawing.'' As 
noted in the preamble to the final rule, the change was made ``to 
provide industry with increased flexibility for developing and 
specifying timeframes for which thawed plasma components can still be 
used for transfusion if stored at

[[Page 43889]]

appropriate temperatures per industry standards.'' (See 77 FR 7 at 14). 
With this regulatory change, CPG Sec. 253.100 is obsolete.
    FDA is therefore withdrawing CPG 253.100, in its entirety, to 
eliminate the obsolete compliance policy.

    Dated: July 16, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-17531 Filed 7-19-13; 8:45 am]